Santa Barbara, CA – Photothermal Spectroscopy Corp. today announced the release of stRAMos™, a next-generation Raman microscope based on photothermal detection of Stimulated Raman scattering, or SRS. This new system delivers unmatched speed, sensitivity, spatial resolution, and multimodal imaging capabilities for life science and materials research. The stRAMos microscope introduces a 10x sensitivity improvement over conventional [...]

BOSTON and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions.   SOPHiA DDM™ Digital Twins uses each patient's unique [...]

HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that MicroVal, the international certification organization for the validation and approval of alternative methods for the microbiological analysis of food and beverages, has approved iQ-Check™ Enterobacteriaceae Kit for the real-time PCR detection of Enterobacteriaceae (EB) in infant formula, infant cereal [...]

Lausanne — Sciencewerke, a leading provider of biomedical and life science solutions, is proud to announce its appointment as the official distributor for VarSome, the comprehensive platform for genomic variant interpretation and analysis, in Singapore, Malaysia, Indonesia, and Thailand. Developed by Saphetor, VarSome is a globally trusted bioinformatics resource used by thousands of researchers, clinicians, and diagnostic [...]

Genovis AB, a leading provider of innovative enzyme technologies, today announced it has received an order with a total value of approximately EUR 1 million (SEK 11 million) from a global pharmaceutical company. The order includes material and related services connected to one of Genovis’ proprietary antibody conjugation technology platforms. Genovis’ technology platform will be [...]

BOSTON -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United States Marine Corps CBRNE Installation and Protection Program purchased 17 of the company’s XplorIR devices for the chemical identification and quantification of hazardous gases and vapors. The program’s mission is to support federal firefighters, military police, post offices [...]

WALTHAM, Mass. --  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines [...]

ROLLE, Switzerland and TOKYO -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic testing to the Japanese population. The companies will also partner to commercialize a liquid biopsy companion diagnostic aimed at advancing personalized and [...]

Tod White Promoted to President; Justin McAnear Appointed Chief Financial Officer FREMONT, Calif. -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced key additions to its executive leadership team. These appointments reflect the company's continued momentum and its commitment to scaling innovation, operational excellence, and strategic growth. The [...]

Merck KGaA, Darmstadt, Germany, is well-positioned for the next wave of growth following strategic portfolio streamlining and targeted investments. Strong position in attractive growth markets due to focused high-tech portfolio and targeted investments Process Solutions, the new Rare Diseases portfolio and Semiconductor Solutions to drive up to 80% of future growth Company targets mid-term annual [...]